Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 9001–9050 of 18437
its Board of Directors had elected Chief Operating Officer Tamria Zertuche as President and Chief Executive Officer, effective August 1, 2023
On July 27, 2023, Ita Brennan, the Company’s Senior Vice President, Chief Financial Officer, notified the Company of her intention to retire in 2024, effective after the Company has hired her replacement to ensure a smooth and orderly transition of her responsibilities.
the appointment of Richard (Rick) R. Isaak, age 55, as Senior Vice President and Chief Financial Officer effective today.
He succeeds Kelly J. Stopher who previously served as Chief Financial Officer.
On July 25, 2023, the Compensation and Benefits Committee of the Board of Directors of American Express Company (the “Company”) approved the following compensation for Christophe Le Caillec in connection with his previously announced appointment as Chief Financial Officer of the Company, effective August 14, 2023
Scott A. Mell, the Company's Chief Financial Officer, will now also act as the Company's principal accounting officer.
On July 25, 2023, the Board of Directors (the “Board”) of Vista Outdoor Inc. (the “Company”) approved for Andrew Keegan, the Chief Financial Officer (Interim) of the Company, certain compensatory changes in connection with his appointment as Chief Financial Officer of the Sporting Products company following the Spin-Off, as described in more detail below.
On July 24, 2023, Salona Global Medical Device Corporation (the “Company”) appointed Michael Seckler, 58, to the position of Chief Executive Officer.
Dr. Gomez will continue to serve as Chief Executive Officer of the Company until the earlier of (A) January 1, 2024, or (B) the date a new Chief Executive Officer commences services with the Company in such role
Vincent A. Verde, who has served with distinction as the Company’s principal financial officer and principal accounting officer since 2018, tendered his resignation as the Principal Financial Officer of the Company, effective as of the Effective Date.
Effective on July 28, 2023, Ms. Eileen P. Drake ceased being an employee of Aerojet Rocketdyne.
Effective on July 28, 2023, Mr. Daniel Boehle ceased being an employee of Aerojet Rocketdyne.
On July 24, 2023, Patrick J. McEnany, the Company’s Chief Executive Officer (“CEO”), informed the Company’s Board of Directors that he intends to retire as the Company’s CEO by the end of 2023.
On July 24, 2023, Christopher McElvany resigned from his positions as Lucy Scientific Discovery Inc.’s (the “Company”) President and Chief Executive Officer (“CEO”) and resigned as a member of the Company’s Board of Directors (the “Board”).
On July 24, 2023, the Board ratified the appointment of Richard Nanula as CEO.
Melvin Paul replaced Dr. Jon Leonard as Chief Financial Officer.
Melvin Paul replaced Dr. Jon Leonard as Chief Financial Officer.
On July 26, 2023 the Board of Directors (the “Board”) of the Company appointed Craig Dais, age 57, as the Company’s Chief Financial Officer, effective upon his start date of July 28, 2023.
Hertz Global Holdings, Inc. (the “Company”) has appointed Alexandra Brooks, 53, as Executive Vice President, Chief Financial Officer, effective July 25 2023
On July 27, 2023, David Yu-Lung Kou resigned as the Acting Chief Executive Officer of the Company.
Effective July 28, 2023, the Board of Directors of the Company appointed Brody J. Wilson as interim Chief Financial Officer of NW Holdings and NW Natural in addition to his current roles.
Effective July 28, 2023, Frank H. Burkhartsmeyer, Executive Vice President, Strategy and Business Development and Chief Financial Officer of Northwest Natural Holding Company (NW Holdings) and its wholly owned subsidiary, Northwest Natural Gas Company (NW Natural), voluntarily resigned his officer positions with NW Holdings and NW Natural.
On July 27, 2023, Sleep Number Corporation (the “Company”) announced that Francis K. Lee has been appointed to the position of Executive Vice President and Chief Financial Officer, effective as of August 14, 2023.
He will assume the role from Chris Krusmark, EVP and Chief Human Resources Officer, who has held the position of Interim CFO since January 2023.
The Company appointed Joseph Risico, age 49, and Arturo Rodriguez, age 48, to succeed Mr. Sarig as the Company’s Co-Chief Executive Officers, effective July 26, 2023.
The Company appointed Joseph Risico, age 49, and Arturo Rodriguez, age 48, to succeed Mr. Sarig as the Company’s Co-Chief Executive Officers, effective July 26, 2023.
On July 26, 2023, Yaniv Sarig notified the Board of Directors (the “Board”) of the Company of his decision to resign as Chief Executive Officer of the Company and from the Board, effective as of July 26, 2023.
Thomas J. Hogan, the current President, will become the Chief Executive Officer of the Company
On July 21, 2023, the Board of Directors (the “ Board ”) of Sagimet Biosciences Inc. (the “ Company ”) appointed Anthony Rimac to Chief Financial Officer, principal financial officer and principal accounting officer of the Company to be effective August 1, 2023.
On July 27, 2023, Chu Chiu Kong was removed as Chief Executive Officer of the Company
On July 27, 2023, Paul Davis was appointed as Chief Executive Officer of the Company and Llewelyn Farquarhson was appointed as Chief Financial Officer of the Company.
On July 27, 2023, Chu Chiu Kong was removed as Chief Executive Officer of the Company, Guilherme Teixeira was removed as Chief Investment Officer of the Company and Fabio Kann was removed as Chief Financial Officer of the Company.
On July 27, 2023, Paul Davis was appointed as Chief Executive Officer of the Company and Llewelyn Farquarhson was appointed as Chief Financial Officer of the Company.
Effective July 25, 2023, Charles Wert was appointed the Company’s Chief Executive Officer
On July 24, 2023, following a search that included internal and external candidates, the Company’s Board of Directors appointed James D. Thomas as Executive Vice President and Chief Financial Officer on a permanent basis.
the Board elected Steven B. Hedlund, age 56, as President and Chief Executive Officer of the Company, effective as of January 1, 2024.
From the Transition Date until a new Global Chief Financial Officer is appointed, Manmohan Mahajan, the Company’s Senior Vice President, Global Controller and Chief Accounting Officer, will serve as Interim Global Chief Financial Officer and principal financial officer.
On July 21, 2023, James Kehoe informed Walgreens Boots Alliance, Inc. (the “Company”) of his decision to resign from his position as Executive Vice President and Global Chief Financial Officer of the Company, effective on July 27, 2023 (the “Transition Date”), in order to pursue a new opportunity.
the Board has appointed Mr. File as CFO and Corporate Secretary, effective as of August 1, 2023
the Board determined that Mr. Drazba’s employment as CFO shall terminate without cause, effective as of the Transition Date
On July 22, 2023, the Company’s board of directors (the “Board”) appointed Kuang Ming (James) Tsai as the Company’s new Chief Financial Officer to fill the vacancy created by the resignation of Shao Cheng (Will) Wang, effective July 22, 2023.
On July 22, 2023, Shao Cheng (Will) Wang resigned from the Chief Financial Officer position of Genufood Energy Enzymes Corp. (the “Company”), effective immediately.
On July 21, 2023 , GameStop Corp. (the “Company”) was informed by Diana Saadeh-Jajeh , the Company’s Chief Financial Officer, that she will resign from such position effective August 11, 2023
On July 27, 2023, in connection with Ms. Saadeh-Jajeh’s resignation, the Board appointed Daniel Moore as the Company’s Principal Accounting Officer and interim Principal Financial Officer effective August 11, 2023
On July 26, 2023, Dennis Becker and the Board of Directors (the “Board”) of Mobivity Holdings Corp. (the “Company”) have mutually agreed that Mr. Becker will resign from his position as the Company’s Chief Executive Officer and Chairman of the Board, effective as of September 1, 2023.
On July 26, 2023, the Company appointed Stephen Jones as the Company’s new Chief Financial Officer.
On July 27, 2023, William “Trey” Martin, III assumed the role of Chief Executive Officer (“CEO”) of Maravai LifeSciences Holdings, Inc.
appointed Richard Dickson as the Company's Chief Executive Officer ("CEO") and President, effective August 22, 2023
The Board has selected Brad Beckham, the Company’s Co-President, to succeed Mr. Johnson as CEO upon Mr. Johnson’s retirement.
Greg Johnson, the Company’s Chief Executive Officer (“CEO”), informed the Company’s Board of Directors (the “Board”) of his intention to retire from the Company effective January 31, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.